These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 16166567)

  • 1. Statin protects endothelial nitric oxide synthase activity in hypoxia-induced pulmonary hypertension.
    Murata T; Kinoshita K; Hori M; Kuwahara M; Tsubone H; Karaki H; Ozaki H
    Arterioscler Thromb Vasc Biol; 2005 Nov; 25(11):2335-42. PubMed ID: 16166567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased endothelial nitric-oxide synthase (eNOS) activity resulting from abnormal interaction between eNOS and its regulatory proteins in hypoxia-induced pulmonary hypertension.
    Murata T; Sato K; Hori M; Ozaki H; Karaki H
    J Biol Chem; 2002 Nov; 277(46):44085-92. PubMed ID: 12185080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. L-arginine restores endothelial nitric oxide synthase-coupled activity and attenuates monocrotaline-induced pulmonary artery hypertension in rats.
    Ou ZJ; Wei W; Huang DD; Luo W; Luo D; Wang ZP; Zhang X; Ou JS
    Am J Physiol Endocrinol Metab; 2010 Jun; 298(6):E1131-9. PubMed ID: 20215577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Κ-opioid receptor stimulation improves endothelial function in hypoxic pulmonary hypertension.
    Wu Q; Wang HY; Li J; Zhou P; Wang QL; Zhao L; Fan R; Wang YM; Xu XZ; Yi DH; Yu SQ; Pei JM
    PLoS One; 2013; 8(5):e60850. PubMed ID: 23667430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylation of endothelial nitric-oxide synthase is diminished in mesenteric arteries from septic rabbits depending on the altered phosphatidylinositol 3-kinase/Akt pathway: reversal effect of fluvastatin therapy.
    Matsuda N; Hayashi Y; Takahashi Y; Hattori Y
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1348-54. PubMed ID: 17003232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial dysfunction and hypercontractility of vascular myocytes are ameliorated by fluvastatin in obese Zucker rats.
    Nishimatsu H; Suzuki E; Satonaka H; Takeda R; Omata M; Fujita T; Nagai R; Kitamura T; Hirata Y
    Am J Physiol Heart Circ Physiol; 2005 Apr; 288(4):H1770-6. PubMed ID: 15550522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Buffered l-ascorbic acid, alone or bound to KMUP-1 or sildenafil, reduces vascular endothelium growth factor and restores endothelium nitric oxide synthase in hypoxic pulmonary artery.
    Wu JR; Kao LP; Wu BN; Dai ZK; Wang YY; Chai CY; Chen IJ
    Kaohsiung J Med Sci; 2015 May; 31(5):241-54. PubMed ID: 25910559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of G(i/o)-Src kinase-PI3K/Akt pathway and caveolin-1 in β₂-adrenoceptor coupling to endothelial NO synthase in mouse pulmonary artery.
    Banquet S; Delannoy E; Agouni A; Dessy C; Lacomme S; Hubert F; Richard V; Muller B; Leblais V
    Cell Signal; 2011 Jul; 23(7):1136-43. PubMed ID: 21385608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A HMG-CoA reductase inhibitor possesses a potent anti-atherosclerotic effect other than serum lipid lowering effects--the relevance of endothelial nitric oxide synthase and superoxide anion scavenging action.
    Sumi D; Hayashi T; Thakur NK; Jayachandran M; Asai Y; Kano H; Matsui H; Iguchi A
    Atherosclerosis; 2001 Apr; 155(2):347-57. PubMed ID: 11254905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The protective effect of HMG-CoA reductase inhibitors against monocrotaline-induced pulmonary hypertension in the rat might not be a class effect: comparison of pravastatin and atorvastatin.
    Rakotoniaina Z; Guerard P; Lirussi F; Goirand F; Rochette L; Dumas M; Bardou M
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Dec; 374(3):195-206. PubMed ID: 17102939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Waon therapy attenuates cardiac hypertrophy and promotes myocardial capillary growth in hypertensive rats: a comparative study with fluvastatin.
    Ihori H; Nozawa T; Sobajima M; Shida T; Fukui Y; Fujii N; Inoue H
    Heart Vessels; 2016 Aug; 31(8):1361-9. PubMed ID: 26686369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hsp90 and caveolin are key targets for the proangiogenic nitric oxide-mediated effects of statins.
    Brouet A; Sonveaux P; Dessy C; Moniotte S; Balligand JL; Feron O
    Circ Res; 2001 Nov; 89(10):866-73. PubMed ID: 11701613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HMG-CoA reductase inhibitor improves endothelial dysfunction in spontaneous hypertensive rats via down-regulation of caveolin-1 and activation of endothelial nitric oxide synthase.
    Suh JW; Choi DJ; Chang HJ; Cho YS; Youn TJ; Chae IH; Kim KI; Kim CH; Kim HS; Oh BH; Park YB
    J Korean Med Sci; 2010 Jan; 25(1):16-23. PubMed ID: 20052342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The HMG-CoA reductase inhibitor, pravastatin, prevents the development of monocrotaline-induced pulmonary hypertension in the rat through reduction of endothelial cell apoptosis and overexpression of eNOS.
    Guerard P; Rakotoniaina Z; Goirand F; Rochette L; Dumas M; Lirussi F; Bardou M
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Sep; 373(6):401-14. PubMed ID: 16896805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tsantan Sumtang, a traditional Tibetan medicine, protects pulmonary vascular endothelial function of hypoxia-induced pulmonary hypertension rats through AKT/eNOS signaling pathway.
    Li N; Su S; Xie X; Yang Z; Li Z; Lu D
    J Ethnopharmacol; 2024 Feb; 320():117436. PubMed ID: 37979813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasculoprotective effect of U50,488H in rats exposed to chronic hypoxia: role of Akt-stimulated NO production.
    Li J; Shi QX; Fan R; Zhang LJ; Zhang SM; Guo HT; Wang YM; Kaye AJ; Kaye AD; Bueno FR; Xu XZ; Yu SQ; Yi DH; Pei JM
    J Appl Physiol (1985); 2013 Jan; 114(2):238-44. PubMed ID: 23139366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-dose rosuvastatin ameliorates lung ischemia-reperfusion injury via upregulation of endothelial nitric oxide synthase and inhibition of macrophage infiltration in rats with pulmonary hypertension.
    Matsuo S; Saiki Y; Adachi O; Kawamoto S; Fukushige S; Horii A; Saiki Y
    J Thorac Cardiovasc Surg; 2015 Mar; 149(3):902-9. PubMed ID: 25454916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced hypoxic pulmonary vascular remodeling by nitric oxide from the endothelium.
    Ozaki M; Kawashima S; Yamashita T; Ohashi Y; Rikitake Y; Inoue N; Hirata KI; Hayashi Y; Itoh H; Yokoyama M
    Hypertension; 2001 Feb; 37(2):322-7. PubMed ID: 11230292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The xanthine derivative KMUP-1 inhibits models of pulmonary artery hypertension via increased NO and cGMP-dependent inhibition of RhoA/Rho kinase.
    Chung HH; Dai ZK; Wu BN; Yeh JL; Chai CY; Chu KS; Liu CP; Chen IJ
    Br J Pharmacol; 2010 Jun; 160(4):971-86. PubMed ID: 20590592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Betamethasone attenuates oxidant stress in endothelial cells from fetal lambs with persistent pulmonary hypertension.
    Chandrasekar I; Eis A; Konduri GG
    Pediatr Res; 2008 Jan; 63(1):67-72. PubMed ID: 18043518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.